These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 21850077)

  • 1. HIV drug-prevention strategy carries risks.
    Hayden EC
    Nature; 2011 Aug; 476(7360):260-1. PubMed ID: 21850077
    [No Abstract]   [Full Text] [Related]  

  • 2. Transmission. Company halts Truvada PrEP for women study.
    AIDS Policy Law; 2011 Jun; 26(7):1. PubMed ID: 21735622
    [No Abstract]   [Full Text] [Related]  

  • 3. HIV/AIDS clinical trials. A powerful and perplexing new HIV prevention tool.
    Cohen J
    Science; 2010 Dec; 330(6009):1298-9. PubMed ID: 21127220
    [No Abstract]   [Full Text] [Related]  

  • 4. HIV pre-exposure prophylaxis.
    Morin SF; Yamey G; Rutherford GW
    BMJ; 2012 Aug; 345():e5412. PubMed ID: 22890030
    [No Abstract]   [Full Text] [Related]  

  • 5. FDA PrEPares to reduce risk of HIV infection with Truvada®.
    Breeze S
    Expert Rev Clin Pharmacol; 2012 Sep; 5(5):499. PubMed ID: 23272332
    [No Abstract]   [Full Text] [Related]  

  • 6. AIDS research. FDA panel recommends anti-HIV drug for prevention.
    Cohen J
    Science; 2012 May; 336(6083):792. PubMed ID: 22605725
    [No Abstract]   [Full Text] [Related]  

  • 7. FDA approves first drug to prevent HIV infection.
    Roehr B
    BMJ; 2012 Jul; 345():e4879. PubMed ID: 22807165
    [No Abstract]   [Full Text] [Related]  

  • 8. PrEP'ing.
    Vázquez E
    Posit Aware; 2012; 24(5):34-8. PubMed ID: 23091881
    [No Abstract]   [Full Text] [Related]  

  • 9. Early end for FEM-PrEP HIV prevention trial.
    AIDS Patient Care STDS; 2011 Jun; 25(6):383. PubMed ID: 21612547
    [No Abstract]   [Full Text] [Related]  

  • 10. HIV prevention trial in women is abandoned after drugs show no impact on infection rates.
    Roehr B
    BMJ; 2011 Apr; 342():d2613. PubMed ID: 21508055
    [No Abstract]   [Full Text] [Related]  

  • 11. Truvada and Epivir are similar at suppressing HIV.
    Proj Inf Perspect; 2009 Mar; (48):5-6. PubMed ID: 19492457
    [No Abstract]   [Full Text] [Related]  

  • 12. Generic Truvada approved.
    AIDS Patient Care STDS; 2009 May; 23(5):395. PubMed ID: 19422066
    [No Abstract]   [Full Text] [Related]  

  • 13. [New fixed combination for HIV therapy].
    Krankenpfl J; 2005; 43(4-6):95. PubMed ID: 16171046
    [No Abstract]   [Full Text] [Related]  

  • 14. Crystallizing the HIV epidemic: methamphetamine, unsafe sex, and gay diseases of the will.
    Worth H; Rawstorne P
    Arch Sex Behav; 2005 Oct; 34(5):483-6. PubMed ID: 16211470
    [No Abstract]   [Full Text] [Related]  

  • 15. Emtricitabine/tenofovir (Truvada) for HIV prophylaxis.
    Coutinho B; Prasad R
    Am Fam Physician; 2013 Oct; 88(8):535-40. PubMed ID: 24364575
    [No Abstract]   [Full Text] [Related]  

  • 16. [PrEP approved in the USA: facts and discussion - permanent chemoprophylaxis for healthy people].
    Marcus U
    MMW Fortschr Med; 2013 Jun; 155 Suppl 1():42-4. PubMed ID: 23961656
    [No Abstract]   [Full Text] [Related]  

  • 17. AIDS research. Complexity surrounds HIV prevention advances.
    Cohen J
    Science; 2011 Jul; 333(6041):393. PubMed ID: 21778370
    [No Abstract]   [Full Text] [Related]  

  • 18. The iPrEx results: lifting hopes, raising questions.
    Auerbach JD
    BETA; 2010; 22(4):47-9. PubMed ID: 21591604
    [No Abstract]   [Full Text] [Related]  

  • 19. [Simply convincing. New fixed combination for HIV therapy].
    MMW Fortschr Med; 2005 Apr; 147 Spec No 1():20-3. PubMed ID: 16385865
    [No Abstract]   [Full Text] [Related]  

  • 20. Mexico conference considers pre-exposure prophylaxis for AIDS.
    Roehr B
    BMJ; 2008 Aug; 337():a1278. PubMed ID: 18703652
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.